Home-Based tDCS Treatment Shows 64% Response Rate in Depression Study

A home-based device that delivers mild electrical currents to the brain achieved a 64% response rate in treating depression—a finding that could reshape mental health care.

The clinical trial involved 60 patients with major depressive disorder who used a transcranial direct current stimulation (tDCS) device at home for 20 minutes daily over four weeks. Researchers observed significant reductions in depression scores comparable to antidepressants.

Dr. Sarah Thompson, the lead researcher:

"Patients used the device for 20 minutes daily, and we observed significant reductions in depression scores comparable to antidepressants."

However, Dr. Michael Green, an independent expert, noted limitations in the study:

"While these results are promising, larger trials are needed to confirm long-term efficacy and safety."

The study’s small sample size (n=60), short follow-up period (4 weeks), and lack of blinding in the design highlight the need for further research. The findings are preliminary and not yet ready for clinical application.

⚠️ LEGAL DISCLAIMER: It is for informational purposes only. It never substitutes for professional medical advice, diagnosis, or treatment. Always consult your doctor regarding any questions about your health.